CIDP/autoimmune nodopathies with nephropathy: a case series study
Annals of Clinical and Translational Neurology2023Vol. 10(5), pp. 706–718
Citations Over TimeTop 10% of 2023 papers
Yuwei Tang, Jing Liu, Feng Gao, Hong-Jun Hao, Zhi-rong Jia, Wei Zhang, Xin Shi, Wei Liang, Meng Yu, He Lv, Ying Tan, Zhiying Li, Yu Wang, Yun Yuan, Lingchao Meng, Zhaoxia Wang
Abstract
Anti-CNTN1 antibody was the most frequent antibody in this group of patients with CIDP/autoimmune nodopathies and nephropathy. Our study suggested that there might be some clinical and pathological differences between the antibody positive and negative patients.
Related Papers
- → Chronic inflammatory demyelinating polyradiculoneuropathy in diabetic patients(2003)68 cited
- → The diagnostic value of sural nerve T cells in chronic inflammatory demyelinating polyneuropathy(1999)54 cited
- [A pathogenic study of chronic inflammatory demyelinating polyradiculoneuropathy in a patient with hepatitis B infection].(1994)
- → Treatment of Inflammatory Demyelinating Polyneuropathy(1999)
- → Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)(2023)